Cite
HARVARD Citation
Kambe, N. et al. (2019). CCL2 serves as a downstream effector of interleukin‐1β and tumour necrosis factor‐α signalling in Schnitzler syndrome. British journal of dermatology. pp. 706-707. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kambe, N. et al. (2019). CCL2 serves as a downstream effector of interleukin‐1β and tumour necrosis factor‐α signalling in Schnitzler syndrome. British journal of dermatology. pp. 706-707. [Online].